EYEES ON
AI eye-tracking diagnostic application for autism.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | KRW100m | Seed | |
| Total Funding | 000k | ||
Based in Jeonju, South Korea, EYEES ON is a privately held company developing a diagnostic application for autism spectrum disorder. The company's core technology utilizes eye-tracking, optimized for an artificial intelligence-based framework, to aid in diagnostics. Functioning in a stealth mode, the company aims to innovate within the diagnostic equipment sector.
The company secured seed funding from Idea Partners on January 5, 2022, which has supported its initial development and operational phases. While specific details about its business model and target clientele remain confidential due to its stealth status, the application is being developed for the industrial revolution powered by AI.
Keywords: autism diagnostics, eye-tracking technology, AI healthcare, diagnostic application, medical technology, autism spectrum disorder, digital health, South Korean startup, neurodevelopmental disorders, AI diagnostics, medtech, healthcare innovation, stealth mode startup, Idea Partners, Jeonju startup, AI medical application, digital diagnostics, neurological disorder tech, health-tech, assistive technology